Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ronran,
And further in the Proxy you get told about this: "The Board has fixed the close of business on March 13, 2007 as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting. As of the record date, the Company had 379,668,118 shares of common stock, $0.00001 par value per share (“Common Stock”), outstanding and entitled to vote." So 1mio more shares between Feb 28th and March 13.
Share
New Message
Please login to post a reply